0 0 0 0 0 -0.0121893250033955 -0.0152451446421296 -0.0146000271628413
Sign Up Today X
Thanks for submitting the form.
Stockreport

CNBC Changemakers and Power Players Podcast: Gilead Sciences Chief Commercial & Corporate Affairs Officer and 2026 CNBC Changemaker Johanna Mercier on ending HIV epidemic, life hacks, and ...

Gilead Sciences, Inc. (GILD)  More Company Research Source: CNBC
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
spoke with Johanna Mercier, Chief Commercial & Corporate Affairs Officer at Gilead Sciences and a 2026 CNBC Changemaker. Mercier discusses Gilead's groundbreaking HIV prevention innovation (a twice-yearly injection with 99.9% efficacy) and how her team moved within months of U.S. approval to expand access across Sub-Saharan Africa, where the need is greatest. She shares why impact (not title) drives her leadership, how personal loss reshaped her sense of purpose, and what it takes to lead through global health crises. Listen to the full episode here . New episodes drop every Tuesday. All references must be sourced to CNBC Changemakers and Power Players podcast. MERCIER ON ENDING HIV EPIDEMIC JULIA BOORSTIN: Tell us about your work over the past couple of years, expanding access to HIV prevention and why this is so important to you. JOHANNA MERCIER: Oh, absolutely. It's a pleasure to talk about this. I work at Gilead Sciences. It's a company that's been focused on HIV for t [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

CNBC Changemakers and Power Players Podcast: Gilead Sciences Chief Commercial & Corporate Affairs Officer and 2026 CNBC Changemaker Johanna Mercier on ending HIV epidemic, life hacks, and ...

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: CNBC
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
spoke with Johanna Mercier, Chief Commercial & Corporate Affairs Officer at Gilead Sciences and a 2026 CNBC Changemaker. Mercier discusses Gilead's groundbreaking HIV prevention innovation (a twice-yearly injection with 99.9% efficacy) and how her team moved within months of U.S. approval to expand access across Sub-Saharan Africa, where the need is greatest. She shares why impact (not title) drives her leadership, how personal loss reshaped her sense of purpose, and what it takes to lead through global health crises. Listen to the full episode here . New episodes drop every Tuesday. All references must be sourced to CNBC Changemakers and Power Players podcast. MERCIER ON ENDING HIV EPIDEMIC JULIA BOORSTIN: Tell us about your work over the past couple of years, expanding access to HIV prevention and why this is so important to you. JOHANNA MERCIER: Oh, absolutely. It's a pleasure to talk about this. I work at Gilead Sciences. It's a company that's been focused on HIV for t [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS